Results 81 to 90 of about 175,097 (273)
ABSTRACT Aims To summarize current evidence on β3‐adrenoceptor agonists for managing neurogenic lower urinary tract dysfunction (NLUTD), focusing on their efficacy, safety, and clinical role in optimizing bladder storage and protecting upper tracts. Methods Evidence from randomized controlled trials, meta‐analyses, and observational studies in spinal ...
Sharon E. Fishberg, Rano Matta
wiley +1 more source
ABSTRACT Aims To evaluate the prevalence, clinical course, and risk factors of lower urinary tract symptoms (LUTS) in patients hospitalized with COVID‐19, and to assess associations with comorbidities, disease severity, and vaccination status. Methods We conducted a prospective cohort study of adult patients hospitalized with confirmed COVID‐19, who ...
Julia Duarte de Souza +12 more
wiley +1 more source
Making Rasch decisions: the use of Rasch analysis in the construction of preference based health related quality of life instruments [PDF]
Objective: To set out the methodological process for using Rasch analysis alongside traditional psychometric methods in the development of a health state classification that is amenable to valuation.
Tsuchiya, A +4 more
core
Overactive bladder: the importance of tailoring treatment to the individual patient
Harold P DrutzDepartment of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Ontario, CanadaOn behalf of the Specialist Advisory Group on OAB (Lake Como, Italy, June 2009)Introduction: Overactive bladder (OAB) is a prevalent and ...
Drutz HP, Michelle Thorpe
core +1 more source
“What Medical Management Should Be First Line for Bladder Storage Symptoms in NLUTD”—Pro Botox
ABSTRACT Objectives Neurogenic lower urinary tract dysfunction (NLUTD) severely impairs patient quality of life (QoL). While oral medications are often first‐line treatments, their high failure rates and side effects limit their effectiveness. Thus, we argue for the use of intravesical botulinum toxin A (BoNT‐A) injections as a first‐line alternative ...
Vada Furlan +2 more
wiley +1 more source
ABSTRACT Aims Neurogenic lower urinary tract dysfunction (NLUTD) describes a wide range of symptoms depending on neurologic diagnosis and the resulting bladder and sphincter dysfunction. This narrative review is designed to address the question regarding which NLUTD population benefits most from pelvic floor therapy and behavioral interventions, and ...
Sara M. Lenherr
wiley +1 more source
ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang +2 more
wiley +1 more source
Background: An overactive bladder is characterized by a persistent urge to urinate, leading to spontaneous urination. Treatment of overactive bladder with mild to moderate exercises and lifestyle changes has been recommended.
Ayesha Zafar +3 more
doaj +1 more source
Evaluating the Effect of Pelvic Floor Muscle Training on Bladder Symptoms Severity and Quality of life among Patients with Overactive Bladder [PDF]
Background: The high prevalence and under-treatment of overactive bladder (OAB) symptoms among adults in Egypt underscore a pressing public health concern.
Walaa Abdelwahab Mohamed +4 more
doaj +1 more source
Pharmacologic management of overactive bladder
Sum Lam1,2, Olga Hilas1,31St. John’s University, College of Pharmacy and Allied Health Professions, Department of Clinical Pharmacy Practice, Queens, New York, USA; 2Division of Geriatric Medicine, Winthrop University Hospital, Mineola, New York ...
Olga Hilas, Sum Lam
core

